CINACALCET

Clinical Indication

Secondary hyperparathyroidism

Comments

Shared care request is mandatory
Full SCA

Date of classification

July 2008

Orange

Shared Care Agreement. Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.